MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Kff.org most likely does not offer any malicious content.
Secure connection support
HTTPS
Kff.org provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Kff.org most likely does not offer any adult content.
Popular pages
-
KFF | The independent source for health policy research, polling, and news
KFF is the independent source for health policy research, polling, and journalism. Our mission is to serve as a nonpartisan source of information for policymakers, the media, the health policy communi...
-
What Could New Anti-Obesity Drugs Mean for Medicare? | KFF
In this piece, we discuss Medicare coverage of obesity treatments, the potential cost implications if Medicare covers anti-obesity drugs, and how the Inflation Reduction Act could potentially address ...
-
Mpox One Year Later: Where is the U.S. today? | KFF
This brief provides an overview of the impact of mpox in the U.S. one year later and the federal response to date, and discusses the future outlook.
-
New Alzheimer’s Drugs Spark Hope for Patients and Cost Concerns for Medicare | KFF
The Food and Drug Administration granted full approval to Leqembi, a new Alzheimer's drug, on July 6, 2023. This updated policy watch focuses on the implications of Medicare coverage of the drug for p...
-
Testimony: Prior Authorization in Medicare Advantage | KFF
Jeannie Fuglesten Biniek, an Associate Director for the Program on Medicare Policy at KFF, testified before the Senate Homeland Security and Government Affairs Committee Permanent Subcommittee on Inve...
-
Jordan Rau | KFF
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff Th...